McKesson Corporation (MCK NYSE) stock market data APIs
$946.3495
-0.22(-0%)
as of October 12, 2026
Try our APIs with
free plan!
McKesson Corporation Financial Data Overview
Price chart is built with
Anychart
McKesson Corporation provides healthcare services in the United States and internationally. It operates through four segments: North American Pharmaceutical, Oncology & Multispecialty, Prescription Technology Solutions, and Medical-Surgical Solutions. The company distributes branded, generic, specialty, biosimilar and over-the-counter pharmaceutical drugs, and other healthcare-related products; delivers products to retail pharmacies, hospitals, long-term care centers, clinics, and institutions; and provides logistics and distribution services for manufacturers. It also provides consulting, outsourcing, technological, and other services, as well as sells financial, operational, and clinical solutions to pharmacies; gene therapy with InspiroGene, practice consulting, and vaccine distribution services; and technology solutions, as well as research, insights, technologies, and services to improve cancer and specialty care. In addition, the company helps in solving medication access, affordability, and adherence challenges for patients by working across healthcare to connect patients, pharmacies, providers, pharmacy benefit managers, health plans, and biopharma companies. Further, it offers technology services, which includes electronic prior authorization, prescription price transparency, benefit insight, dispensing support services, patient enrollment, third-party logistics, and wholesale distribution support; medical-surgical supplies, laboratory equipment, pharmaceutical distribution, logistics, and other services to healthcare providers, including physician offices, surgery centers, hospital reference labs, nursing homes, hospice and home health care agencies, government facilities, and online marketplaces and retailers. McKesson Corporation was founded in 1833 and is headquartered in Irving, Texas.
Prev. Close
946.3495
Open
946.1302
High
957.5895
Low
931.4609
52 wk Range
722.1132-996.8371
Market Cap
111 432 M
P/E Ratio
25.6167
Shares Outstanding
117 M
Revenue
410 983 M
EPS
9.93
Dividends (Yield)
0.0035
Beta
0.298
* We provide hundreds of fields of fundamental data, including EBITDA, P/E ratio, PEG ratio, trailing P/E, shareholders, insider transactions, technical metrics, dividends, splits, earnings, and more. Check out our Fundamental Data API.
ETFs with McKesson Corporation (top by weight)
Ticker
100-day Price Change
Weight
* We provide detailed information about ETF constituents through our Fundamentals API for ETFs. Read the documentation to learn more.
Why to choose EODHD?
Prices start at $19.99
24/7 Live support
Robust, powerful and reliable data
API Simplicity of a few lines of code
Try our APIs
with free plan!
Or get access to advanced financial data starting only $19.99
TRY NOW
Get McKesson Corporation data using free add-ons & libraries
Get McKesson Corporation Fundamental Data
McKesson Corporation Fundamental data includes:
- Net Revenue: 410 983 M
- EBITDA: 7 071 M
- Earnings Per Share: 37
- Income Statements
- Balance Sheets
- Cash flows
Plans with Fundamental data
Starting from
$
59.99
/mo.
End-of-day & Earnings data
What’s included:
- Latest Release: 2026-08-05
- EPS/Forecast: 9.44
What’s included:
- End of Day, Intraday and Live APIs
- Splits
- Dividends
McKesson Corporation News
New
3 Large-Cap Stocks to Keep an Eye On
3 Large-Cap Stocks to Keep an Eye On Large-cap stocks have the power to shape entire industries thanks to their size and widespread influence. With such vast footprints, however, finding new areas fo...
McKesson (MCK) Stock Could Be 43% Undervalued Despite Its $1.4B Infusion Deal
McKesson has been a powerful long term winner. With the share price now at US$938.84, the real question is whether the business can keep generating cash flows that line up with that kind of run. With ...
McKesson (MCK) Extends CVS Deal, Is The Stock Fully Valued?
McKesson (MCK) shares are in focus after the distributor reached an agreement in principle to extend its pharmaceutical distribution partnership with CVS Health through June 2032, reinforcing a long-r...
Does New CVS and EPIC Deals Reshape McKesson’s Pharmacy Distribution Narrative (MCK)?
In October 2026, EPIC Pharmacies introduced a new wholesale distribution model naming McKesson as one of two primary partners, while McKesson separately announced an agreement in principle to extend i...
Get McKesson Corporation fresh news feed via Financial News API
Corporate Events Calendar & News package for
$19.99/mo.
Try our APIs
with free plan!
Or get access to advanced financial data starting only $19.99
TRY NOW
- Flexibility: No long-term commitments, just a minimum of one month
- Instant access: Get your API key and instructions within seconds of subscribing
Best Offer
All-In-One
$99.99/mo.
What’s included:
- API Calls per Day: 100 000/day
- API Requests per Min.: 1000/minute
- Type of Usage: Personal use
Data access:
Historical EOD, Fundamental, Real-Time, Intraday, Live (Delayed), Technical & Screener APIs, News Feed, 40 000 Stock Logos and many more. See a full list.